Gartisertib (VX-803) is an orally active and selective Rad3-related protein (ATR) inhibitor with antitumor activity, inhibiting the antiproliferative effect induced in ccRCC cells, and inhibiting ATR-driven phosphorylation of checkpoint kinase 1 (Chk1), useful for studying solid tumors.
Molekulargewicht:
541.55
Reinheit:
99.52%
CAS Nummer:
[1613191-99-3]
Formel:
C25H29F2N9O3
Target-Kategorie:
ATM/ATR
T10407
T10407
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten